UNBS5162
目录号: A15439
CXCL chemokines 拮抗剂
UNBS5162 是一种新型萘酰亚胺化合物，能够降低实验性前列腺癌中的 CXCL 趋化因子表达；在9种癌症细胞系中，其平均抗增殖活性 IC50 值为17.9 uM；是 UNBS3157 的水解产物。
顾客使用 Adooq 产品发表的高质量科研文献
生物活性
| Discription | UNBS5162 is a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers; the mean antiproliferative activity IC50 value is 17.9 uM for 9 cancer cell lines; hydrolysis product of UNBS3157. | ||
|---|---|---|---|
| Targets |
|
产品信息
| 目录号 | A15439 |
|---|---|
| 分子式 | C17H18N4O3 |
| 分子量 | 326.35 |
| CAS号 | 956590-23-1 |
| SMILES | CN(C)CCN1C(=O)C2=CC=CC3=CC(=CC(=C32)C1=O)NC(=O)N |
| 其他名称 | UNBS 5162, UNBS-5162 |
| 储存条件 | Store lyophilized at -20ºC, keep desiccated. |
溶解性数据
| In vitro | DMSO | 16 mg/mL (49.03 mM) | |
| Water | Insoluble | ||
| Ethanol | Insoluble | ||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
Preparing Stock Solutions
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 30.64 mL | 153.21 mL | 306.42 mL |
| 0.5 mM | 6.13 mL | 30.64 mL | 61.28 mL |
| 1 mM | 3.06 mL | 15.32 mL | 30.64 mL |
| 5 mM | 0.61 mL | 3.06 mL | 6.13 mL |
Useful Calculator
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
Keywords: 购买 UNBS5162 | UNBS5162 供应商 | UNBS5162 花费 | UNBS5162 生产商 | 订购 UNBS5162 | UNBS5162 代理商
| 购买 956590-23-1 | 956590-23-1 供应商 | 956590-23-1 花费 | 956590-23-1 生产商 | 订购 956590-23-1 | 956590-23-1 代理商